A Pilot Study of Liposomal Doxorubicin Combined With Bevacizumab Followed by Bevacizumab Monotherapy in Patients With Advanced Kaposi Sarcoma

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-3528